Abstract
THE thalidomide molecule contains an asymmetric carbon atom, but the form of the drug which has been used therapeutically and which has produced congenital malformations in man is the optically inactive form, that is (±)-thalidomide. The optical antipodes of thalidomide have been synthesized1,2, and Dr A. M. Creighton has supplied samples of both (+)- and (−)-thalidomide. The (+)-isomer, melting point 240°–241° C, showed [α]D20+60° (c = 2 in dimethylformamide) and the (−)-isomer, melting point 241°–242° C; showed [α]D20−58° (c = 2 in dimethylformamide). (±)-Thalidomide has a melting point of 271° C and, of course, is optically inactive. With these samples, we have determined the acute oral toxicities of the three forms in mice, their teratogenic activity in the New Zealand white rabbit and their effect on the hypnosis induced by hexobarbitone in mice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Casini, G., and Ferappi, M., Farmaco Ed. Sci., 19, 563 (1964).
Shealy, Y. F., Opliger, C. E., and Montgomery, J. A., Chem. Indust, 1030 (1965).
Fabro, S., and Smith, R. L., J. Path. Bact., 91, 511 (1966).
Fabro, S., Schumacher, H., Smith, R. L., Stagg, R. B. L., and Williams, R. T., Brit. J. Pharmacol., 25, 352 (1965).
Williams, R. T., Schumacher, H., Fabro, S., and Smith, R. L., in Embryopathic Activity of Drugs (edit. by Robson, J. M., Sullivan, F. and Smith, R. L.), 169 (J. and A. Churchill, Ltd., London, 1965).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
FABRO, S., SMITH, R. & WILLIAMS, R. Toxicity and Teratogenicity of Optical Isomers of Thalidomide. Nature 215, 296 (1967). https://doi.org/10.1038/215296a0
Received:
Issue date:
DOI: https://doi.org/10.1038/215296a0


